SOPH
USDSOPHiA GENETICS SA Ordinary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$4.820
Kõrge
$5.110
Madal
$4.630
Maht
0.18M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
316.3M
Tööstusharu
Health Information Services
Riik
Switzerland
Kauplemisstatistika
Keskmine maht
0.09M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
BTIG Maintains Buy on Sophia Genetics, Raises Price Target to $7
BTIG analyst Mark Massaro maintains Sophia Genetics with a Buy and raises the price target from $6 to $7.
SOPHiA GENETICS Reports Third Quarter 2025 Results and Increases 2025 Revenue Guidance
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the third quarter ended...
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Highlights Third quarter 2025 revenue of $205.7 million decreased by 4% year-over-year but was flat when excluding previously discussed headwinds1 of $8.1 million, consistent with management expectations.Third quarter
SOPHiA GENETICS to Announce Financial Results for Third Quarter 2025 on November 4, 2025
SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the third...
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.